News

Deal Announcements

Conatus Pharma Lands $20 Million Venture Capital

Monday, February 14, 2011 5:34:00 AM PDT | VentureDeal Staff
   San Diego, California  --  Conatus Pharmaceuticals has raised $20 million in its second round of institutional venture capital investment, according to a company statement.

Conatus is developing pan caspase inhibitors used in the science of apoptosis.

AgeChem Venture Fund led the round, which also included Aberdare Ventures, Advent Venture Partners, Bay City Capital, Glide Healthcare Partners and Roche Venture Fund.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1